Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ViewPoint Therapeutics logo — company profile

ViewPoint Therapeutics

Founded 2014 Series B Total: $39.00M Biotechnology, Health Care +1

General Information

Company Name ViewPoint Therapeutics
Founded Year 2014
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with ViewPoint Therapeutics. To contact ViewPoint Therapeutics, visit viewpointtherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ViewPoint Therapeutics compare?

A PDF of ViewPoint Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ViewPoint Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ViewPoint Therapeutics

ViewPoint Therapeutics is a biotechnology company founded in 2014 with a focus on developing treatments for diseases caused by protein misfolding, such as cataracts. The company's crystallin stabilizers include a small molecule that has shown activity in preclinical models of age-related cataracts through a target-based screening and optimization effort. This approach aims to provide physicians with medications to prevent or reverse protein misfolding, addressing numerous common disorders of aging, including cataracts, presbyopia, and neurodegenerative diseases. The company has recently received a significant $35.00M Series B investment at 05 March 2018 from a group of prominent investors including Mission Bay Capital, The Rise Fund, BVF Partners, Mission BioCapital, Novo Ventures, and Lagunita BioSciences LLC. This infusion of capital signifies a significant level of confidence in ViewPoint Therapeutics' innovative approach and potential to make a meaningful impact in the realm of biotechnology and healthcare. With a focus on addressing prevalent age-related disorders, the company's efforts align with the growing demand for effective treatments in the healthcare industry.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $35.00M 6
Mission Bay Capital The Rise Fund Mission BioCapital
Mission Bay Capital, The Rise Fund +4
05 Mar 2018
Series A $4.00M 3
Asset Management Ventures Mission Bay Capital Lagunita Biosciences
Asset Management Ventures, Mission Bay Capital +1
05 May 2016

ViewPoint Therapeutics Alternatives & Competitors

ViewPoint Therapeutics vs
Rubedo Life Sciences
Rubedo Life Sciences United States

Medicines to keep you biologically young by targeting the pathological cells that drive chronic dise...

Series A
32 employees
Biotechnology, Health Care

FAQ About ViewPoint Therapeutics

ViewPoint Therapeutics is a biotechnology company focused on developing treatments for diseases caused by protein misfolding, such as cataracts. The company's crystallin stabilizers include a small molecule that has shown activity in preclinical models of age-related cataracts through a target-based...
ViewPoint Therapeutics was founded in 2014.
ViewPoint Therapeutics operates in Biotechnology, Health Care and Health and Wellness.
ViewPoint Therapeutics has completed 2 funding rounds, raising a total of $39.00M. The latest funding stage is Series B.
Top alternatives and competitors to ViewPoint Therapeutics include Rubedo Life Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ViewPoint Therapeutics and Rubedo Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ViewPoint Therapeutics, https://bouncewatch.com/company/viewpoint-therapeutics, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes